Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women.
Journal
Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089
Informations de publication
Date de publication:
09 03 2023
09 03 2023
Historique:
received:
02
09
2022
revised:
03
11
2022
accepted:
07
12
2022
pmc-release:
14
12
2023
pubmed:
15
12
2022
medline:
11
3
2023
entrez:
14
12
2022
Statut:
ppublish
Résumé
Although unopposed estrogen exposure is considered a major driver of endometrial carcinogenesis, chronic inflammation and insulin resistance and hyperinsulinemia are also major endometrial cancer risk factors. However, it is unclear whether diets with inflammatory or insulinemic potential are associated with risk of endometrial cancer. We followed 48 330 women from the Nurses' Health Study (1984-2016) and 85 426 women from the Nurses' Health Study II (1989-2017). Using food frequency questionnaires, we calculated repeated measures of empirical dietary inflammatory pattern (EDIP) and empirical dietary index for hyperinsulinemia (EDIH) scores, which characterize the potential of the whole diet to modulate circulating biomarkers of inflammation or C-peptide, respectively. We used multivariable-adjusted Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for type I endometrial cancer risk. We documented 1462 type I endometrial cancer cases over 2 823 221 person-years of follow-up. In the pooled multivariable-adjusted analyses, women in the highest compared with lowest quintiles were at higher risk of type I endometrial cancer (EDIP HRQ5vsQ1 = 1.46, 95% CI = 1.24 to 1.73; Ptrend < .001; EDIH HRQ5vsQ1 = 1.58, 95% CI = 1.34 to 1.87; Ptrend < .001). Additional adjustment for body mass index attenuated the associations (EDIP HR = 1.03, 95% CI = 0.87 to 1.22; EDIH HR = 1.01, 95% CI = 0.85 to 1.21), and mediation analyses showed that body mass index may explain 60.4% (95% CI = 37.4% to 79.6%; P < .001) and 71.8% (95% CI = 41.0% to 90.4%; P < .001) of the association of endometrial cancer with EDIP and EDIH, respectively. In this large cohort study, higher dietary inflammatory and insulinemic potential were each associated with increased endometrial cancer incidence, and this association may be almost entirely mediated by adiposity.
Sections du résumé
BACKGROUND
Although unopposed estrogen exposure is considered a major driver of endometrial carcinogenesis, chronic inflammation and insulin resistance and hyperinsulinemia are also major endometrial cancer risk factors. However, it is unclear whether diets with inflammatory or insulinemic potential are associated with risk of endometrial cancer.
METHODS
We followed 48 330 women from the Nurses' Health Study (1984-2016) and 85 426 women from the Nurses' Health Study II (1989-2017). Using food frequency questionnaires, we calculated repeated measures of empirical dietary inflammatory pattern (EDIP) and empirical dietary index for hyperinsulinemia (EDIH) scores, which characterize the potential of the whole diet to modulate circulating biomarkers of inflammation or C-peptide, respectively. We used multivariable-adjusted Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for type I endometrial cancer risk.
RESULTS
We documented 1462 type I endometrial cancer cases over 2 823 221 person-years of follow-up. In the pooled multivariable-adjusted analyses, women in the highest compared with lowest quintiles were at higher risk of type I endometrial cancer (EDIP HRQ5vsQ1 = 1.46, 95% CI = 1.24 to 1.73; Ptrend < .001; EDIH HRQ5vsQ1 = 1.58, 95% CI = 1.34 to 1.87; Ptrend < .001). Additional adjustment for body mass index attenuated the associations (EDIP HR = 1.03, 95% CI = 0.87 to 1.22; EDIH HR = 1.01, 95% CI = 0.85 to 1.21), and mediation analyses showed that body mass index may explain 60.4% (95% CI = 37.4% to 79.6%; P < .001) and 71.8% (95% CI = 41.0% to 90.4%; P < .001) of the association of endometrial cancer with EDIP and EDIH, respectively.
CONCLUSIONS
In this large cohort study, higher dietary inflammatory and insulinemic potential were each associated with increased endometrial cancer incidence, and this association may be almost entirely mediated by adiposity.
Identifiants
pubmed: 36515492
pii: 6900939
doi: 10.1093/jnci/djac229
pmc: PMC9996217
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-321Subventions
Organisme : NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA218694
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA272529
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
J Nutr. 2016 Aug;146(8):1560-70
pubmed: 27358416
Am J Clin Nutr. 1999 Feb;69(2):243-9
pubmed: 9989687
Cancer Epidemiol. 2015 Apr;39(2):170-3
pubmed: 25649355
Int J Cancer. 2019 Oct 1;145(7):1719-1730
pubmed: 30387875
J Natl Cancer Inst. 2021 Apr 6;113(4):381-389
pubmed: 33225344
Cancer Causes Control. 2010 Nov;21(11):1817-28
pubmed: 20640883
Future Oncol. 2014 Dec;10(16):2561-8
pubmed: 25531045
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):971-7
pubmed: 21415362
Am J Clin Nutr. 2018 Aug 1;108(2):363-370
pubmed: 29901698
Am J Epidemiol. 2017 Apr 1;185(7):570-584
pubmed: 28338828
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):921-9
pubmed: 18398032
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
Adv Nutr. 2021 Jul 30;12(4):1160-1176
pubmed: 33570108
Am J Public Health. 2016 Sep;106(9):1624-30
pubmed: 27459454
Int J Cancer. 2017 Feb 1;140(3):600-610
pubmed: 27770434
J Nutr. 2019 May 1;149(5):804-815
pubmed: 31004153
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Eur J Cancer. 2015 Dec;51(18):2747-58
pubmed: 26597445
Cancers (Basel). 2021 Apr 29;13(9):
pubmed: 33946913
Circulation. 2000 Jul 4;102(1):42-7
pubmed: 10880413
Cancer Causes Control. 2020 Feb;31(2):203-207
pubmed: 31823169
Cancer Causes Control. 2007 Nov;18(9):967-88
pubmed: 17638104
Cancers (Basel). 2020 Sep 08;12(9):
pubmed: 32911852
Clin Nutr. 2020 Jun;39(6):1681-1691
pubmed: 31477367
Am J Epidemiol. 1994 Dec 1;140(11):1016-9
pubmed: 7985649
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
Endocr Relat Cancer. 2010 Oct 29;17(4):1007-19
pubmed: 20843938
Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):113-115
pubmed: 29284671
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):466-71
pubmed: 25662427
BMC Cancer. 2020 Feb 5;20(1):101
pubmed: 32024485
Eur J Cancer Prev. 2013 Jul;22(4):374-9
pubmed: 23702681
Am J Epidemiol. 2018 May 1;187(5):1051-1063
pubmed: 29036411
J Nutr. 2017 Aug;147(8):1567-1577
pubmed: 28659407
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1004-11
pubmed: 24998076
Stat Med. 1997 Jul 15;16(13):1515-27
pubmed: 9249922
Recent Results Cancer Res. 2016;208:107-136
pubmed: 27909905
Am J Epidemiol. 1985 Jul;122(1):51-65
pubmed: 4014201
J Obstet Gynaecol Res. 2022 Mar;48(3):774-795
pubmed: 35048465
Diabetes Care. 2020 Nov;43(11):2675-2683
pubmed: 32873589
Cancer Med. 2022 Feb;11(4):1145-1159
pubmed: 35048536
Br J Nutr. 2016 Jan 14;115(1):138-46
pubmed: 26507451
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1531-43
pubmed: 12496040
J Womens Health. 1997 Feb;6(1):49-62
pubmed: 9065374
Am J Epidemiol. 1992 May 15;135(10):1114-26; discussion 1127-36
pubmed: 1632423
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2279-2286.e3
pubmed: 31712072
J Clin Oncol. 2016 Dec 10;34(35):4225-4230
pubmed: 27903150
Clin Nutr ESPEN. 2021 Apr;42:22-31
pubmed: 33745582
Br J Nutr. 2016 Nov 28;116(10):1787-1798
pubmed: 27821188
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Adv Nutr. 2021 Oct 1;12(5):1681-1690
pubmed: 33873204
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2384-94
pubmed: 24273064
Eur J Epidemiol. 2021 Aug;36(8):827-839
pubmed: 33331993
Nutrients. 2019 Oct 02;11(10):
pubmed: 31581675